Recommendation and Guideline
- Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
-
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
-
J Liver Cancer. 2023;23(2):241-261. Published online July 14, 2023
-
DOI: https://doi.org/10.17998/jlc.2023.05.22
-
-
12,180
Views
-
335
Downloads
-
20
Citations
-
Abstract
PDF
- Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients with hepatocellular carcinoma (HCC) and was established as conventional TACE using Lipiodol in the 1980s. In the 2000s, drug-eluting beads were developed and applied clinically. Currently, TACE is a commonly used non-surgical treatment modality for patients with HCC who are unsuitable for curative treatment. Considering the vital role of TACE in the management of HCC, it is crucial to organize current knowledge and expert opinions regarding patient preparation, procedural techniques, and post-treatment care in TACE, which can enhance therapeutic efficacy and safety. A group of 12 experts in the fields of interventional radiology and hepatology, convened by the Research Committee of the Korean Liver Cancer Association (KLCA), has developed expert consensus-based practical recommendations in TACE. These recommendations have been endorsed by the Korean Society of Interventional Radiology and provide useful information and direction in performing TACE procedure as well as pre- and post- procedural patient care.
-
Citations
Citations to this article as recorded by

- All You Need to Know About TACE: A Comprehensive Review of Indications, Techniques, Efficacy, Limits, and Technical Advancement
Carolina Lanza, Velio Ascenti, Gaetano Valerio Amato, Giuseppe Pellegrino, Sonia Triggiani, Jacopo Tintori, Cristina Intrieri, Salvatore Alessio Angileri, Pierpaolo Biondetti, Serena Carriero, Pierluca Torcia, Anna Maria Ierardi, Gianpaolo Carrafiello
Journal of Clinical Medicine.2025; 14(2): 314. CrossRef - Case report: Transarterial chemoembolization for nasal hemangiosarcoma in a dog
Keunho Kim, Changgyu Lim, Songyi Kim, Hearang Lim, Sang-Hwan Hyun, Byeong-Teck Kang, Dongwoo Chang, Namsoon Lee
Frontiers in Veterinary Science.2025;[Epub] CrossRef - Transarterial Chemoembolization: A Consistent and Continuously Evolving Therapy for Hepatocellular Carcinoma
Amar Mukund, Niraj Kumar, Amol Srivastava, Akhil Baby
Journal of Clinical and Experimental Hepatology.2025; 15(4): 102538. CrossRef - Silibinin-Conjugated Galactose Dendrimers for Targeted Treatment of Hepatocellular Carcinoma
Aqib Iqbal Dar, Vikrantvir Jain, Anu Rani, Anunay James Pulukuri, Joan Castaneda Gonzalez, Anubhav Dhull, Rishi Sharma, Anjali Sharma
ACS Applied Materials & Interfaces.2025; 17(14): 20980. CrossRef - Conventional transcatheter arterial chemoembolization with gelatin spheres for hepatocellular carcinoma: comparison with nonspherical gelatin sponge particles
Dong Il Gwon, Hee Ho Chu, Gun Ha Kim, Jihoon Kim, Byoung Soo Im, Eunbyeol Ko, Jeongyeon Kim, Jin Hyoung Kim, Gi-Young Ko, Hyun-Ki Yoon
European Radiology.2025; 35(9): 5835. CrossRef - Synergistic effects of L-arginine and argininosuccinate synthetase 1 in inducing apoptosis in hepatocellular carcinoma
Jin Sun Kim, Won-Mook Choi, Ha-Il Kim, Sung Won Chung, Jonggi Choi, Danbi Lee, Kang Mo Kim
Journal of Liver Cancer.2025; 25(1): 79. CrossRef - Optimizing Yttrium-90 Radioembolization Dosimetry for Hepatocellular Carcinoma: A Korean Perspective
In Joon Lee, Hyo-Cheol Kim
Korean Journal of Radiology.2025; 26(7): 688. CrossRef - LI-RADS CT/MRI Treatment Response Assessment Update in 2024
Jaeseung Shin, Kyowon Gu, Ji Hye Min
Journal of the Korean Society of Radiology.2025; 86(3): 352. CrossRef - Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma
Brandon M. Meyers, Howard J. Lim, Mayur Brahmania, Dave M. Liu, Vincent C. Tam, Deanna McLeod, Ravi Ramjeesingh, Jennifer J. Knox, Arndt Vogel
Therapeutic Advances in Medical Oncology.2025;[Epub] CrossRef - Fucoidan Improves Tumour Control and Liver Function in TACE for Unresectable Hepatocellular Carcinoma: A Randomised Trial
Yanting Zou, Szu‐Yuan Wu, Wanqin Zhang, Wei Zhang, Xizhong Shen, Xudong Qu, Qunyan Yao
Liver International.2025;[Epub] CrossRef - Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria
Hyun Yang, Soon Sun Kim, Seong Hee Kang, Jieun Kwon, Do Young Kim, Eunju Kim, Hyun Phil Shin, Jeong Il Yu, Jeong-Ju Yoo, Eileen L. Yoon, Sangheun Lee, Young Eun Chon, Janghan Jung, Jaekyung Cheon, Woosun Choi, Seul Ki Han, Ji Eun Han, Moon Haeng Hur, Hyun
Journal of Liver Cancer.2025; 25(2): 160. CrossRef - Post-embolisation syndrome trajectories and predictors in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: A retrospective study
Myoung Soo Kim
European Journal of Oncology Nursing.2025; 79: 103031. CrossRef - Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis
Manuel Lim, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
Journal of Liver Cancer.2024; 24(1): 102. CrossRef - A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
Hae Lim Lee, Seok Hwan Kim, Hee Yeon Kim, Sung Won Lee, Myeong Jun Song
Frontiers in Oncology.2024;[Epub] CrossRef - Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
Jungnam Lee, Young‐Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Jung Hwan Yu, Jin‐Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim
Journal of Gastroenterology and Hepatology.2024; 39(9): 1924. CrossRef - Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
Yuri Cho, Bo Hyun Kim, Young-Suk Lim
Digestive Disease Interventions.2024; 08(03): 169. CrossRef - Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
Kaige Deng, Tong Chen, Zijian Leng, Fan Yang, Tao Lu, Jingying Cao, Weixuan Pan, Yongchang Zheng
La radiologia medica.2024; 129(8): 1099. CrossRef - Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis
Jae Hwan Lee, Kun Yung Kim, Chong-ho Lee, Minuk Kim, Chang Jin Yoon
Journal of Liver Cancer.2024; 24(2): 217. CrossRef - TACE vs. TARE for HCC ≥ 8 cm: A propensity score analysis
Nhan Hien Phan, Ho Jong Chun, Jung Suk Oh, Su Ho Kim, Byung Gil Choi
Abdominal Radiology.2024; 50(3): 1198. CrossRef - Implications of the first edition of the Korean expert consensus-based practice recommendations for transarterial chemoembolization in the management of hepatocellular carcinoma
Jin Wook Chung
Journal of Liver Cancer.2023; 23(2): 235. CrossRef
Review Article
- Radioembolization for hepatocellular carcinoma: what clinicians need to know
-
Jin Woo Choi, Hyo-Cheol Kim
-
J Liver Cancer. 2022;22(1):4-13. Published online February 23, 2022
-
DOI: https://doi.org/10.17998/jlc.2022.01.16
-
-
23,548
Views
-
812
Downloads
-
23
Citations
-
Abstract
PDF
- Transarterial radioembolization (TARE) with yttrium 90 (90Y) has been used in the management of hepatocellular carcinoma (HCC) for more than 10 years in Korea. There are two types of 90Y radioactive microspheres available, namely, glass and resin microspheres, with comparable clinical outcomes. In general, TARE outperforms transarterial chemoembolization regarding post-embolization syndrome, time to progression, tumor downsizing for liver transplantation, and hospitalization stay. Although TARE is commonly recommended for patients with unresectable large HCCs, it can be an alternative to or performed in combination with ablation, surgical resection, and systemic treatment. This review aimed to address 90Y radioactive microspheres, patient selection, clinical outcomes, simulation tests, radioembolization procedures, follow-up imaging, and complications.
-
Citations
Citations to this article as recorded by

- Advances and Emerging Techniques in Y-90 Radioembolization for Hepatocellular Carcinoma
Elliott L. Fite, Mina S. Makary
Cancers.2025; 17(9): 1494. CrossRef - Eco-Friendly Approaches in Oncology: Developing Holmium (166Ho) Glass Microspheres for Hepatocellular Radioembolization
Sara Rhaissa Rezende dos Reis, Natália Cristina Gomes-da-Silva, Luciana Magalhães Rebelo Alencar, Alan Silva de Menezes, Frederico Duarte de Menezes, Kirill S. Golokhvast, Eduardo Ricci-Junior, Ralph Santos-Oliveira
ACS Omega.2025; 10(22): 22426. CrossRef - Hepatocellular Carcinoma: Review of Indian Literature
Vaishnavi Konda, Shanthi Vijayaraghavan
Gastroenterology, Hepatology and Endoscopy Practice.2025; 5(3): 95. CrossRef - Comparative Evaluation of Intraarterial Therapy Methods for Hepatocellular Cancer
A. P. Petrosyan, V. V. Kucherov, Yu. A. Emelyanova, A. D. Kaprin, S. A. Ivanov, L. O. Petrov, N. A. Falaleeva, A. G. Isaeva, A. S. Dikova, A. T. Stekhova, E. A. Volicheva
Russian Journal of Gastroenterology, Hepatology, Coloproctology.2025; 35(2): 45. CrossRef - LI-RADS TRA V2024: innovations in imaging assessment of hepatocellular carcinoma response to locoregional therapies
Alexandre Key Wakate Teruya, Joao Miranda, Hilton Leão Filho, Daniel Lahan-Martins, Cassia Tamura Sttefano Guimaraes, Roberto Blasbalg, Fernanda Garozzo Velloni
Abdominal Radiology.2025;[Epub] CrossRef - Assessment of Preprocedural Factors Associated with 5-Year Complete Response After Transarterial Radioembolization in Patients with Hepatocellular Carcinoma
June Park, Dong Kyu Kim, Seungsoo Lee, Shin Hye Hwang
Diagnostics.2025; 15(18): 2297. CrossRef - Radioembolization for hepatocellular carcinoma
Yoselin Dos Santos Poleo, Abrahams Ocanto Martínez
Revisiones en Cáncer.2025;[Epub] CrossRef - The hepatic arterial system variations: A systematic review with meta-analysis
Adrian Balcerzak, George Triantafyllou, Fotis Demetriou, Maria Piagkou, Łukasz Olewnik
Annals of Anatomy - Anatomischer Anzeiger.2025; : 152752. CrossRef - Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150
Masatoshi Kudo, Tatsuya Yamashita, Richard S. Finn, Peter R. Galle, Michel Ducreux, Ann-Lii Cheng, Kaoru Tsuchiya, Naoya Sakamoto, Shuhei Hige, Ryosuke Take, Kyoko Yamada, Yuki Nakagawa, Hayato Takahashi, Masafumi Ikeda
Liver Cancer.2025; 14(5): 539. CrossRef - Unlocking Precision in Radioembolization: Navigating the Future of Holmium-166 Radioembolization Mapping and Lung Shunt Study by Implementing Scout Dosimetry
Peiman Habibollahi, Armeen Mahvash, Nima Kokabi, Nariman Nezami
CardioVascular and Interventional Radiology.2024; 47(4): 451. CrossRef - Feasibility of Liver Transplantation after 90Y Radioembolization: Lessons from a Radiation Protection Incident
Marine Soret, Jacques-Antoine Maisonobe, Philippe Maksud, Stéphane Payen, Manon Allaire, Eric Savier, Charles Roux, Charlotte Lussey-Lepoutre, Aurélie Kas
Health Physics.2024; 127(3): 373. CrossRef - Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management
Cody R. Criss, Mina S. Makary
Current Oncology.2024; 31(4): 2076. CrossRef - Selective internal radiation therapy segmentectomy: A new minimally invasive curative option for primary liver malignancies?
Riccardo Inchingolo, Francesco Cortese, Antonio Rosario Pisani, Fabrizio Acquafredda, Roberto Calbi, Riccardo Memeo, Fotis Anagnostopoulos, Stavros Spiliopoulos
World Journal of Gastroenterology.2024; 30(18): 2379. CrossRef - Transarterial radioembolization vs transarterial chemoembolization with drug-eluting beads for treating hepatocellular carcinoma: a cost-effectiveness analysis in Japanese healthcare system
Go Shirota, So Sato, Hideo Yasunaga, Shotaro Aso, Masaaki Akahane, Daisuke Itoh, Osamu Abe
Japanese Journal of Radiology.2024; 42(12): 1501. CrossRef - Combining liver-directed and immunotherapy in advanced hepatocellular carcinoma: A review and future directions
Pranav Kumar, Chase J. Wehrle, Keyue Sun, Chunbao Jiao, Rebecca Panconesi, Mingyi Zhang, Noah X. Tocci, Hanna Hong, Abby Gross, Erlind Allkushi, Maureen Whitsett Linganna, Andrea Schlegel, Toms Augustin, Charles Miller, David CH Kwon, Kazunari Sasaki, Fed
Surgical Oncology Insight.2024; 1(4): 100100. CrossRef - Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment
Hyungjin Rhee, Young Nyun Park, Jin-Young Choi
Korean Journal of Radiology.2024; 25(10): 887. CrossRef - Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinoma
Kelly Hao, Andrew J Paik, Lauren H Han, Mina S Makary
World Journal of Radiology.2024; 16(10): 512. CrossRef - Radiation Safety Assessment of 177Lu-DOTATATE Intra-arterial Peptide Receptor Therapy (PRRT)
Manoj Kumar Hariram Chauhan, Ashish Kumar Jha, Sneha Mithun, Rutuja Dasharath Parab, Pooja Dwivedi, Ameya D Puranik, Kunal Bharat Gala, Nitin Sudhakar Shetye, Suyash Kulkarni, Venkatesh Rangarajan
Indian Journal of Nuclear Medicine.2024; 39(4): 254. CrossRef - Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
Sung Won Chung, Heejin Cho, Hyunjae Shin, Jeayeon Park, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Myungsu Lee, Yoon Jun Kim, Jin Chul Paeng, Jung-Hwan Yoon, Jin Wook Chung, Jeong-Hoon Lee, Hyo-Cheol Kim
Frontiers in Oncology.2023;[Epub] CrossRef - The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review
Brandon M. Meyers, Jennifer J. Knox, David M. Liu, Deanna McLeod, Ravi Ramjeesingh, Vincent C. Tam, Howard J. Lim
Cancer Treatment Reviews.2023; 118: 102584. CrossRef - Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors
Cody R. Criss, Mina S. Makary
Biology.2023; 12(7): 999. CrossRef - Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region
Imam Waked, Sherif Alsammany, Sayed Hammad Tirmazy, Kakil Rasul, Jafar Bani‐Issa, Wael Abdel‐Razek, Ashraf Omar, Amr Shafik, Salem Eid, Amr Abdelaal, Ahmed Hosni, Gamal Esmat
Liver International.2023; 43(10): 2062. CrossRef - Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study
Heechul Nam, Hyun Yang, Ho Soo Chun, Han Ah Lee, Joon Yeul Nam, Jeong Won Jang, Yeon Seok Seo, Do Young Kim, Yoon Jun Kim, Si Hyun Bae
Cancers.2023; 15(21): 5195. CrossRef